• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1981 年至 2020 年美国系统性硬化症死亡率的长期趋势。

Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020.

机构信息

Department of General Medicine, China Medical University Hospital, No. 2, Yude Rd., North District, Taichung 404327, Taiwan.

School of Medicine, China Medical University, Taichung 404327, Taiwan.

出版信息

Int J Environ Res Public Health. 2022 Nov 16;19(22):15088. doi: 10.3390/ijerph192215088.

DOI:10.3390/ijerph192215088
PMID:36429809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9690027/
Abstract

BACKGROUND

Systemic sclerosis (SSc) has the highest mortality rate among autoimmune disorders. Individuals with SSc frequently die from complications or infections related to SSc. Nonetheless, the sex-age-period interaction of SSc is complex and remains unclear. The study aims to analyze the secular trend of SSc mortality based on data regarding underlying cause of death (UCD) and multiple causes of death (MCD) and clarify the sex-age interaction with time.

METHODS

The multiple-cause mortality statistics provided by the National Center for Health Statistics were used to identify all deaths in the United States from 1981 to 2020 in which SSc was indicated anywhere on the death certificates. The age-standardized mortality rate (ASMR) was determined for both sexes, as well as the variations in these rates. Joinpoint regression analysis was utilized to determine the annual percentage change (APC) of ASMR.

RESULTS

A total of 44,672 and 66,259 individuals who died between 1981 and 2020 were identified based on the UCD and MCD data, respectively. According to the UCD data, SSc-related AMSR (SSc-ASMR) of the male and female decedents, respectively, declined from 5.01 and 1.94 in 1981-1990 to 4.77 and 1.32 in 2011-2020, respectively (mortality rate ratio 0.95, 95% confidence interval 0.92-0.98). From 1986 to 1999, the APC of SSc-ASMR in female decedents decreased except for those aged 45-64 years (APC 2.1%, = 0.002). For MCD analysis, in trend 1, only APC of SSc-ASMR in male decedents aged 45-64 years decreased. The SSc-ASMR of both male and female decedents fell on trend 2 arm. In 2011-2020, the ratio of UCD to MCD increased across all age groups for both sexes compared to 1981-1990. Overall, compared to the male decedents, the SSc-ASMR in female decedents increased significantly before 1999, peaked in 1999, followed by continuous decrease until 2020 according to UCD and MCD statistics.

CONCLUSIONS

Over the past four decades, the SSc deaths based on the MCD data were 1.48 times more than the UCD data, and the proportion of UCD over MCD increased over time. The SSc-ASMRs in all the sex-age groups significantly decreased over the past two decades. Notably, the mortality rate ratio of women to men with SSc increased in the past four decades.

摘要

背景

系统性硬化症 (SSc) 是自身免疫性疾病中死亡率最高的疾病。患有 SSc 的人经常因与 SSc 相关的并发症或感染而死亡。尽管如此,SSc 的性别-年龄-时期相互作用仍很复杂,目前尚不清楚。本研究旨在根据死因根本原因(UCD)和多种死因(MCD)数据分析 SSc 死亡率的长期趋势,并阐明随时间推移的性别-年龄相互作用。

方法

利用国家卫生统计中心提供的多死因死亡率统计数据,确定了美国在 1981 年至 2020 年间所有死因证书上注明有 SSc 的死亡病例。确定了男女的年龄标准化死亡率(ASMR)以及这些比率的变化。使用 Joinpoint 回归分析确定 ASMR 的年百分比变化(APC)。

结果

根据 UCD 和 MCD 数据,分别确定了 1981 年至 2020 年期间共有 44672 人和 66259 人死亡。根据 UCD 数据,男性和女性死者的 SSc 相关 ASMR(SSc-ASMR)分别从 1981-1990 年的 5.01 和 1.94 降至 2011-2020 年的 4.77 和 1.32(死亡率比 0.95,95%置信区间 0.92-0.98)。1986 年至 1999 年,除 45-64 岁女性死者外,SSc-ASMR 的 APC 均呈下降趋势(APC 2.1%,=0.002)。对于 MCD 分析,在趋势 1 中,只有 45-64 岁男性死者的 SSc-ASMR APC 下降。男女死者的 SSc-ASMR 均呈趋势 2 手臂。2011-2020 年,与 1981-1990 年相比,男女所有年龄组的 UCD 与 MCD 的比例均有所增加。总体而言,根据 UCD 和 MCD 统计数据,与男性死者相比,女性死者的 SSc-ASMR 在 1999 年之前显著增加,在 1999 年达到峰值,随后持续下降至 2020 年。

结论

在过去的四十年中,基于 MCD 数据的 SSc 死亡人数是 UCD 数据的 1.48 倍,并且 UCD 相对于 MCD 的比例随时间增加。在过去的二十年中,所有性别-年龄组的 SSc-ASMR 均显著下降。值得注意的是,在过去的四十年中,患有 SSc 的女性与男性的死亡率比增加了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/9690027/0f0f1e20e334/ijerph-19-15088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/9690027/bcc6e9c897ef/ijerph-19-15088-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/9690027/0f0f1e20e334/ijerph-19-15088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/9690027/bcc6e9c897ef/ijerph-19-15088-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4da9/9690027/0f0f1e20e334/ijerph-19-15088-g002.jpg

相似文献

1
Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020.1981 年至 2020 年美国系统性硬化症死亡率的长期趋势。
Int J Environ Res Public Health. 2022 Nov 16;19(22):15088. doi: 10.3390/ijerph192215088.
2
Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.系统性硬化症死亡率趋势:48 年研究(1968-2015):一项基于美国人群的研究。
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1502-1510. doi: 10.1002/acr.24411. Epub 2021 Aug 31.
3
Mortality associated with osteoporosis and pathological fractures in the United States (1999-2020): a multiple-cause-of-death study.美国 1999-2020 年骨质疏松症和病理性骨折相关死亡率:一项多死因研究。
J Orthop Surg Res. 2024 Sep 16;19(1):568. doi: 10.1186/s13018-024-05068-1.
4
Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades.过去五十年中,系统性硬化症的死亡率在年轻患者中呈稳步下降趋势。
Rheumatology (Oxford). 2024 Feb 1;63(2):466-471. doi: 10.1093/rheumatology/kead233.
5
Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data.根据潜在病因和多种死因死亡率数据,1981 年至 2020 年美国皮肌炎和多发性肌炎死亡率的长期长期趋势。
Arthritis Res Ther. 2023 Jan 31;25(1):16. doi: 10.1186/s13075-022-02963-y.
6
Temporal Trends in Mortality in Patients with Systemic Sclerosis in Public Hospitals Across Mexico from 1998-2017.1998-2017 年墨西哥公立医院系统性硬化症患者死亡率的时间趋势。
Arch Med Res. 2022 Sep;53(6):610-616. doi: 10.1016/j.arcmed.2022.07.005. Epub 2022 Aug 26.
7
46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study.1968年至2013年美国系统性红斑狼疮死亡率的46年趋势:一项基于全国人口的研究。
Ann Intern Med. 2017 Dec 5;167(11):777-785. doi: 10.7326/M17-0102. Epub 2017 Oct 31.
8
Distinct mortality profile in systemic sclerosis: a death certificate study in Rio de Janeiro, Brazil (2006-2015) using a multiple causes of death analysis.系统性硬化症的死亡率特征不同:巴西里约热内卢(2006-2015 年)的死亡证明研究,采用多死因分析法。
Clin Rheumatol. 2019 Jan;38(1):189-194. doi: 10.1007/s10067-017-3951-8. Epub 2017 Dec 16.
9
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA.美国系统性硬化症及系统性硬化症相关肺动脉高压的死亡率趋势。
ERJ Open Res. 2020 Jun 15;6(2). doi: 10.1183/23120541.00309-2019. eCollection 2020 Apr.
10
Animal-Encounter Fatalities, United States, 1999-2016: Cause of Death and Misreporting.动物致伤致死事件,美国,1999-2016 年:死亡原因和误报情况。
Public Health Rep. 2020 Nov/Dec;135(6):831-841. doi: 10.1177/0033354920953211. Epub 2020 Sep 15.

引用本文的文献

1
Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis.自体造血细胞移植治疗系统性硬化症患者的安全性和长期疗效
Front Med (Lausanne). 2025 Jul 14;12:1527779. doi: 10.3389/fmed.2025.1527779. eCollection 2025.

本文引用的文献

1
New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics.系统性硬化症治疗的新时代:近期获批的疗法
J Clin Med. 2022 Aug 8;11(15):4631. doi: 10.3390/jcm11154631.
2
Geographic disparity in systemic sclerosis mortality in the United States: 1999-2017.1999 - 2017年美国系统性硬化症死亡率的地区差异
J Scleroderma Relat Disord. 2021 Jun;6(2):139-145. doi: 10.1177/2397198319869566. Epub 2019 Aug 26.
3
Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.
系统性硬皮病相关肺动脉高压患者死亡率增加:系统评价和荟萃分析。
Adv Rheumatol. 2022 Mar 30;62(1):10. doi: 10.1186/s42358-022-00239-2.
4
Epidemiology and Trends in Survival of Systemic Sclerosis in Olmsted County (1980-2018): A Population-based Study.奥尔姆斯特德县系统性硬化症的流行病学与生存趋势(1980 - 2018年):一项基于人群的研究
J Scleroderma Relat Disord. 2021 Oct;6(3):264-270. doi: 10.1177/23971983211026853. Epub 2021 Jun 23.
5
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis.利妥昔单抗治疗系统性硬化症有效吗?系统评价和荟萃分析。
Adv Rheumatol. 2021 Feb 27;61(1):15. doi: 10.1186/s42358-021-00170-y.
6
Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.系统性硬化症死亡率趋势:48 年研究(1968-2015):一项基于美国人群的研究。
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1502-1510. doi: 10.1002/acr.24411. Epub 2021 Aug 31.
7
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA.美国系统性硬化症及系统性硬化症相关肺动脉高压的死亡率趋势。
ERJ Open Res. 2020 Jun 15;6(2). doi: 10.1183/23120541.00309-2019. eCollection 2020 Apr.
8
Renal Involvement in Systemic Sclerosis: An Update.系统性硬化症的肾脏累及:最新进展。
Kidney Blood Press Res. 2020;45(4):532-548. doi: 10.1159/000507886. Epub 2020 Jun 10.
9
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.2001 年至 2014 年期间,自身免疫性系统性疾病全因死亡率的全球趋势。
Autoimmun Rev. 2020 Jun;19(6):102531. doi: 10.1016/j.autrev.2020.102531. Epub 2020 Mar 29.
10
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature.系统性硬化症的生存和预后因素:一项法国多中心队列研究、系统评价和文献荟萃分析的数据。
Arthritis Res Ther. 2019 Apr 3;21(1):86. doi: 10.1186/s13075-019-1867-1.